Cytotoxic CD4+ T cells and autoimmune fibrotic disorders
Cytotoxic CD4+ T cells and autoimmune fibrotic disorders
批准号:
10394916
负责人:
SHIV Subramaniam PILLAI
金额:
$25.2万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-01 至 2024-04-30
关键词:
AntigensApoptosisApoptoticAutoantigensAutoimmuneB-Cell ActivationB-Lymphocyte EpitopesB-Lymphocyte SubsetsB-LymphocytesBiologyBiopsyBlood VesselsCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCell DeathCell surfaceCellsCessation of lifeColorCytotoxic T-LymphocytesDataDiseaseEnzymesFibroblastsFibrosisGenerationsGranzymeHematopoietic stem cellsIgG4ImageImmuneIn SituInterleukin-1Interleukin-4LesionLinkMolecularMyofibroblastPathogenesisPathway interactionsPatientsPeptidesPlasmablastPopulationPrincipal InvestigatorProcessProductionSiteSomatic MutationSystemic SclerodermaT cell differentiationT-LymphocyteT-Lymphocyte EpitopesTestingTissuesVariantbasecytokinecytotoxicmacrophagemicrobialmicrobiomemicroorganism antigenmucosal sitenovelperforinprofibrotic cytokineprogramsrepairedtertiary lymphoid organtranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
This project focuses on the underlying basis of an autoimmune fibrotic disorder, IgG4-
related disease. We will use multi-color multispectral imaging of disease tissues, cell
distance mapping as well as single-cell transcriptomics to interrogate tissues from IgG4-
related disease. In particular we wish to identify and quantitate CD4+cytotoxic T cells
and activated B cell subsets and better understand whether they directly contribute to
cell death in tissues and thus to fibrosis, or if they primarily secrete fibrogenic products.
We also want to understand the molecular basis by which CD4+cytotoxic T cells
differentiate. We will test two competing but mutually non-exclusive hypotheses - one
that CD4+T cells, with the help of activated B cells drive tissue cell death as a prelude to
fibrosis, and the other that the cytokines and enzymes secreted by activated T cells and
disease-related B cells are causal for fibrosis. We will also examine the interactions
between adaptive and innate immune cells in disease and identify antigens that trigger
clonally expanded B and T cells in patients. We will also explore the possibility that
somatic mutations in hematopoietic stem cells or in CD4+CTL clones contribute to
disease pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training Program in Immunological Tolerance and Autoimmunity
-
批准号:9102896
-
项目类别:
-
资助金额:$18.74万
-
财政年份:2015
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Training Program in Immunological Tolerance and Autoimmunity
-
批准号:9264976
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2015
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Training Program in Immunological Tolerance and Autoimmunity
-
批准号:8933644
-
项目类别:
-
资助金额:$18.55万
-
财政年份:2015
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
An Autoimmune center of excellence for the study of IgG4-related disease
-
批准号:8680709
-
项目类别:
-
资助金额:$71.29万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Coordinating an ACE studying IgG4-related diseases
-
批准号:10188398
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Admin-Core-001
-
批准号:10794460
-
项目类别:
-
资助金额:$63.89万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
An autoimmune center of excellence for the study of IgG4-related disease
-
批准号:9915860
-
项目类别:
-
资助金额:$44.9万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Studies on the Immunology of IgG4-related diseases
-
批准号:8732923
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Coordinating an ACE studying IgG4-related diseases
-
批准号:10394915
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
An autoimmune center of excellence for the study of IgG4-related disease
-
批准号:10188397
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
An autoimmune center of excellence for the study of IgG4-related disease
-
批准号:10394914
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Cytotoxic CD4+ T cells and autoimmune fibrotic disorders
-
批准号:10188399
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
An autoimmune center of excellence for the study of IgG4-related disease
-
批准号:10609833
-
项目类别:
-
资助金额:$63.89万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Inducing neutralizing antibodies to HIV by inhibiting SIAE
-
批准号:8291408
-
项目类别:
-
资助金额:$90.46万
-
财政年份:2010
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Mutations in the SIAE Gene and Susceptibility to Autoimmune Diseases
-
批准号:8070140
-
项目类别:
-
资助金额:$2.87万
-
财政年份:2010
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Inducing neutralizing antibodies to HIV by inhibiting SIAE
-
批准号:8473774
-
项目类别:
-
资助金额:$55.71万
-
财政年份:2010
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Inducing neutralizing antibodies to HIV by inhibiting SIAE
-
批准号:8089346
-
项目类别:
-
资助金额:$67.15万
-
财政年份:2010
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Human Memory B cells in Humanized Mice
-
批准号:7876327
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2010
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Human Memory B cells in Humanized Mice
-
批准号:8103171
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2010
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Inducing neutralizing antibodies to HIV by inhibiting SIAE
-
批准号:7989356
-
项目类别:
-
资助金额:$63.74万
-
财政年份:2010
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: